These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36329124)

  • 1. The lncRNA THOR interacts with and stabilizes hnRNPD to promote cell proliferation and metastasis in breast cancer.
    Hu H; Zhang H; Xing Y; Zhou Y; Chen J; Li C; Xu J; Guo Y; Wang J; He Q; Liu X; Sheng J; Song E; Wu Y; Huang H
    Oncogene; 2022 Dec; 41(49):5298-5314. PubMed ID: 36329124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HNRNPD is a prognostic biomarker in non-small cell lung cancer and affects tumor growth and metastasis via the PI3K-AKT pathway.
    Fan G; Li D; Liu J; Tao N; Meng C; Cui J; Cai J; Sun T
    Biotechnol Genet Eng Rev; 2024 Nov; 40(3):1571-1590. PubMed ID: 36971333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TPI1 activates the PI3K/AKT/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5.
    Jin X; Wang D; Lei M; Guo Y; Cui Y; Chen F; Sun W; Chen X
    J Transl Med; 2022 May; 20(1):191. PubMed ID: 35509067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
    Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S
    Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 6. Long non-coding RNA THOR promotes cell proliferation and metastasis in hepatocellular carcinoma.
    Cheng Z; Lei Z; Yang P; Si A; Xiang D; Zhou J; Hüser N
    Gene; 2018 Dec; 678():129-136. PubMed ID: 30098425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
    Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA
    Wu H; He Y; Chen H; Liu Y; Wei B; Chen G; Lin H; Lin H
    FEBS Open Bio; 2019 Apr; 9(4):781-790. PubMed ID: 30984551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA KB-1980E6.3 promotes breast cancer progression through the PI3K/AKT signalling pathway.
    He L; Tang L; Wang R; Liu L; Zhu P; Jiang K; Tu G
    Pathol Res Pract; 2022 Jun; 234():153891. PubMed ID: 35461041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
    Liu J; Chen M; Ma L; Dang X; Du G
    Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
    Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA THOR acts as a retinoblastoma promoter through enhancing the combination of c-myc mRNA and IGF2BP1 protein.
    Shang Y
    Biomed Pharmacother; 2018 Oct; 106():1243-1249. PubMed ID: 30119193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA TP73-AS1 promoted the progression of lung adenocarcinoma via PI3K/AKT pathway.
    Liu C; Ren L; Deng J; Wang S
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30541897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
    Yuan J; Xu XJ; Lin Y; Chen QY; Sun WJ; Tang L; Liang QX
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):198-206. PubMed ID: 30657561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.
    Wang Y; Liu C; Xie Z; Lu H
    Chem Biol Interact; 2020 Feb; 317():108960. PubMed ID: 31981573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA LOXL1-AS1 Promotes the Proliferation and Metastasis of Medulloblastoma by Activating the PI3K/AKT Pathway.
    Gao R; Zhang R; Zhang C; Liang Y; Tang W
    Anal Cell Pathol (Amst); 2018; 2018():9275685. PubMed ID: 30050750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA PART1 restrains aggressive gastric cancer through the epigenetic silencing of PDGFB via the PLZF-mediated recruitment of EZH2.
    Han H; Wang S; Meng J; Lyu G; Ding G; Hu Y; Wang L; Wu L; Yang W; Lv Y; Jia S; Zhang L; Ji J
    Oncogene; 2020 Oct; 39(42):6513-6528. PubMed ID: 32901105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.